COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 1262: Articles 12611-12620  | Next

COVID-19 attack ratio among children critically depends on the time to removal and activity levels
Wu, J., Bragazzi, N. L., Scarabel, F., McCarthy, Z., David, J., LIAM/ADERSIM COVID-19 Reopening and Recovery Modeling Group
10.1101/2021.09.25.21263542 — Posted: 2021-09-27
Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections
Kennedy, A. E., Cook, L., Breznik, J. A., Cowbrough, B., Wallace, J. G., Huynh, A., Smith, J. W., Son, K., Stacey, H., Ang, J., McGeer, A., Coleman, B. L., Larche, M., Larche, M., Hambly, N., Nair, P., Ask, K., Miller, M. S., Bramson, J., Levings, M. K., Nazy, I., Svenningsen, S., Mukherjee, M., Bowdish, D. M.
10.1101/2021.09.25.21264117 — Posted: 2021-09-27
Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern
Fisman, D., Tuite, A.
10.1101/2021.09.25.21264097 — Posted: 2021-09-27
The Pandemic Brain: neuroinflammation in healthy, non-infected individuals during the COVID-19 pandemic
Brusaferri, L., Alshelh, Z., Martins, D., Kim, M., Weerasekera, A., Housman, H., Morrisey, E. J., Knight, P. C., Castro-Blanco, K. A., Albrecht, D. S., Tseng, C.-E., Zurcher, N. R., Ratai, E.-M., Johnson-Akeju, O., Mercaldo, N. D., Hadjikhani, N., Veronese, M., Turkheimer, F., Rosen, B. R., Hooker, J. M., Loggia, M. L.
10.1101/2021.09.21.21263740 — Posted: 2021-09-27
Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California.
Stoddard, G., Black, A., Ayscue, P., Lu, D., Kamm, J., Bhatt, K., Chan, L., Kistler, A. L., Batson, J., Detweiler, A., Tan, M., Neff, N., DeRisi, J. L., Corrigan, J.
10.1101/2021.09.21.21258385 — Posted: 2021-09-27
Modeling the transmission of the SARS-CoV-2 delta variant in a partially vaccinated population
Avila, U., Avila, E., Huang, K.-l.
10.1101/2021.09.23.21264032 — Posted: 2021-09-26
SARS-CoV-2 vaccines breakthrough infection hospitalizations after one dose in Libya: cohort study
Abdelhamid, M. H. M., Al msellati, I. A., Annajar, B. B., Abdelhamid, A. H., alemam, H., Eltikar, M.
10.1101/2021.09.26.21263691 — Posted: 2021-09-26
Viroporin activity of SARS-CoV-2 Orf3a and Envelope protein impacts viral pathogenicity
Sarkar, M., Etheimer, P., Saha, S.
10.1101/2021.09.26.461873 — Posted: 2021-09-26
Deactivation of SARS-CoV-2 surrogate porcine epidemic diarrhea virus with electron beam irradiation under the cold chain transportation condition
Liu, Y., Shao, Y., Wang, L., Lu, W., Li, S., Xu, D., Fu, Y. V.
10.1101/2021.09.25.461766 — Posted: 2021-09-26
Cytotoxic T-cell-based vaccine against SARS-CoV2: a hybrid immunoinformatic approach
Tirziu, A., Paunescu, V.
10.1101/2021.09.26.461851 — Posted: 2021-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).